Full Press Release Details
regeneron and intellia announce expanded research collaboration to develop crispr based therapies for the treatment of neurological and muscular diseases.
REGN
regeneron and intellia announce expanded research collaboration to develop crispr based therapies for the treatment of neurological and muscular diseases
Key Takeaway: regeneron and intellia announce expanded research collaboration to develop crispr based therapies for the treatment of neurological and muscular diseases